AU Patent

AU2010320598B2 — Compositions for treating centrally mediated nausea and vomiting

Assigned to Helsinn Healthcare SA · Expires 2016-06-16 · 10y expired

What this patent protects

Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.

USPTO Abstract

Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010320598B2
Jurisdiction
AU
Classification
—
Expires
2016-06-16
Drug substance claim
No
Drug product claim
No
Assignee
Helsinn Healthcare SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.